Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-07-07

Clinical Trial Update: Rheumatoid Arthritis Dose Ranging Study (0663-086)(COMPLETED) [Phase 2]

View source ↗

Summary

Phase 2 dose-ranging trial for rheumatoid arthritis completed; results posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Organon and Co | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2009-07-07